Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer

Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study

Research output: Contribution to journal › Journal article › Research › peer-review

Presentation
Citation formats

Kristine H Allin
Nordestgaard, Børge
Henrik Flyger
Bojesen, Stig Egil

We examined whether plasma C-reactive protein (CRP) levels at the time of diagnosis of breast cancer are associated with overall survival, disease-free survival, death from breast cancer, and recurrence of breast cancer.

Original language	English
Journal	Breast Cancer Research (Online Edition)
Volume	13
Issue number	3
Pages (from-to)	R55
ISSN	1465-5411
DOIs	https://doi.org/10.1186/bcr2891
Publication status	Published - 2011

ID: 40139117